News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|August 7, 2015

Pancreatic Cancer: A Caregiver's Perspective

Episodes in this series

EP. 1 What Pancreatic Cancer Is and The Risk Factors

EP. 1 What Pancreatic Cancer Is and The Risk Factors

EP. 2 A Cancer Patient's First-Hand Account of a Pancreatic Cancer Diagnosis

EP. 2 A Cancer Patient's First-Hand Account of a Pancreatic Cancer Diagnosis

EP. 3 Blood Tests, Biopsies, and Symptoms

EP. 3 Blood Tests, Biopsies, and Symptoms

EP. 4 Treatment Options for Pancreatic Cancer

EP. 4 Treatment Options for Pancreatic Cancer

EP. 5 Research for Pancreatic Cancer

EP. 5 Research for Pancreatic Cancer

EP. 6 Pancreatic Cancer: Staying Positive

EP. 6 Pancreatic Cancer: Staying Positive

EP. 7 Top Tips for Pancreatic Cancer Patients

EP. 7 Top Tips for Pancreatic Cancer Patients

EP. 8 Pancreatic Cancer: A Caregiver's Perspective

EP. 8 Pancreatic Cancer: A Caregiver's Perspective

EP. 9 Pancreatic Cancer: Coping With the Disease

EP. 9 Pancreatic Cancer: Coping With the Disease

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Dr. Ariel Ostad explains how addressing uncertainty and scananxiety through communication and support can improve the cancer care experience for patients.

The Emotional Side of Cancer Care Beyond Medical Treatment

January 28th 2026

Image of Tracy.

Managing Nutrition Changes in Patients With Gastrointestinal Cancers

ByDr. Tracy Proverb-Sign

January 28th 2026

Image of Kim.

Grieving After Cancer: Advice for Those Grieving and Supporting Them

January 28th 2026

A phase 2 trial showed onvansertib plus FOLFIRI and Avastin improved response and disease control in first-line RAS-mutated metastatic colorectal cancer: © stock.adobe.com.

Onvansertib Combo Improves Outcomes in First-Line RAS-Mutated mCRC

January 28th 2026

FDA

FDA Grants Orphan Drug Status to CTD402 for Rare T-Cell Blood Cancers

January 28th 2026

Trending on CURE

Cancer and Answering the Phone

Onvansertib Combo Improves Outcomes in First-Line RAS-Mutated mCRC

Beyond Statistics: Lessons in Mindset and Action from a Cancer Survivor

FDA Approves Darzalex Faspro-VRd For Newly Diagnosed, Transplant Ineligible Multiple Myeloma

Grieving After Cancer: Advice for Those Grieving and Supporting Them